 |
Total Revenues
 |
$4.5 billion
 |
$5.3 billion
 |
$4.7 billion
 |

Operating earnings1 |
$315.9 million* |
$64.9 million |
$142.6 million*** |
|
Per share operating earnings1 |
$2.03* |
$0.44 |
$0.92*** |
|
Net income (loss)2 |
$330.0 million* |
$(2.83) billion** |
$98.2 million*** |
|
Per share net income (loss)2 |
$2.12* |
$(19.00)** |
$0.63*** |
* Includes approximately $107 million after tax, or $0.69 per share, of favorable development of prior-period medical cost estimates.
** Net loss in the first quarter 2002 reflects the recording of $50 million income from discontinued operations and the recording of a $2.97 billion noncash impairment of goodwill, resulting from the adoption of a new accounting standard FAS 142, "Goodwill and Other Intangible Assets." Income from continuing operations, which is before these items, was $88.0 million, or $0.59 per share.
*** Includes approximately $23 million after tax, or $0.15 per share, of favorable development of prior-period medical cost estimates.
|
|  |